Zirgan^® (ganciclovir ophthalmic gel) 0.15%

Zirgan is available by prescription through U.S. pharmacies and is stocked at all major U.S. pharmaceutical wholesalers.

Share with a colleague

What does Zirgan offer physicians and patients?

• Zirgan represents the first innovation in the topical ophthalmic antiviral class in the U.S. in over 30 years.
• Zirgan provides an enhanced dosing regimen over current topical therapies.
• Zirgan is designed to target herpes virus infected cells.

Indications and Usage

Zirgan is indicated for the treatment of acute herpetic keratitis (dendritic ulcers). The recommended dosing for Zirgan is one drop five times per day until the corneal ulcer heals, and then one drop three times per day for seven days.

Important Risk Information for Zirgan

Zirgan is indicated for topical ophthalmic use only. Patients should not wear contact lenses if they have signs or symptoms of herpetic keratitis or during the course of therapy with Zirgan. The most common adverse reactions reported in patients were blurred vision (60%), eye irritation (20%), punctate keratitis (5%) and conjunctival hyperemia (5%).

Please see complete information about Zirgan by downloading the Zirgan Package Insert today.